VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 118 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.52 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $776,000 | -66.5% | 45,280 | -57.9% | 0.00% | -71.4% |
| Q2 2021 | $2,314,000 | +43.2% | 107,600 | 0.0% | 0.01% | +27.3% |
| Q1 2021 | $1,616,000 | +14.3% | 107,600 | 0.0% | 0.01% | +10.0% |
| Q4 2020 | $1,414,000 | +13.9% | 107,600 | -16.3% | 0.01% | +11.1% |
| Q3 2020 | $1,241,000 | -31.2% | 128,500 | -18.5% | 0.01% | -40.0% |
| Q2 2020 | $1,803,000 | -41.8% | 157,600 | -47.3% | 0.02% | -6.2% |
| Q1 2020 | $3,096,000 | +207.1% | 298,800 | +147.8% | 0.02% | +45.5% |
| Q1 2016 | $1,008,000 | -75.3% | 120,600 | -71.4% | 0.01% | -79.2% |
| Q4 2015 | $4,084,000 | – | 422,300 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 1,532,000 | $27,423,000 | 3.23% |
| Stonepine Capital Management, LLC | 300,000 | $5,370,000 | 3.16% |
| Palo Alto Investors LP | 4,155,670 | $74,386,000 | 3.13% |
| GREAT POINT PARTNERS LLC | 497,531 | $8,906,000 | 1.73% |
| Avoro Capital Advisors LLC | 988,270 | $17,690,000 | 1.37% |
| UNIVERSITY OF NOTRE DAME DU LAC | 157,781 | $2,824,000 | 0.79% |
| Birchview Capital, LP | 68,000 | $1,217,000 | 0.63% |
| Cheyne Capital Management (UK) LLP | 74,000 | $1,323,000 | 0.48% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 352,604 | $6,311,000 | 0.43% |
| 361 CAPITAL LLC | 119,554 | $2,140,000 | 0.41% |